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論 文 内 容 の 要 旨 
 
Alzheimer’s disease (AD) and cerebrovascular disorder are the major causes of 
dementia in which aging and vascular disorders are implicated as risk factors. Because 
of worldwide population aging, the number of people with dementia is dramatically 
increasing in many countries and providing social and economic impacts in terms of 
medical and social costs. Therefore, development of new drugs and therapeutic 
strategies effective for prevention/therapy of dementia are greatly needed. Bacopa 
monnieri (L) Wettst. (BM) is a medicinal plant which has been not only used as a 
traditional medicine to improve intelligence and memory but also taken as vegetables in 
Vietnam for a long time. In this study, we investigated the anti-dementia effects of BM 
alcohol extract in mice with olfactory bulbectomy (OBX) and transient cerebral ischemia 
(T2VO) used as experimental models of AD and vascular dementia, respectively. 
Moreover, to have a better understanding the molecular mechanism(s) underlying the 
effects of BM, we investigated neuroprotective effects of tacrine (THA), an 
acetylcholinesterase inhibitor, and bacopaside I, a terpenoid saponin isolated from BM, 
in organotypic hippocampal slice cultures (OHSCs). 
 
I. Bacopa monnieri ameliorates memory deficits in olfactory bulbectomized mice: 
Possible involvement of glutamatergic and cholinergic systems (1) 
This study investigated the effects of alcoholic extract of BM on cognitive deficits 
using olfactory bulbectomized (OBX) mice and the underlying molecular mechanisms of 
its action. OBX mice were treated daily with BM (50 mg/kg, p.o.) or a reference drug 
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THA (2.5 mg/kg, i.p.) 1 week before and continuously 3 days after OBX. Cognitive 
performance of the animals was analyzed by the novel object recognition test, modified 
Y maze test, and fear conditioning test. Brain tissues of OBX animals were used for 
neurochemical and immunohistochemical studies. OBX impaired non-spatial 
short-term memory, spatial working memory, and long-term fair memory. BM 
administration ameliorated these memory disturbances. The effect of BM on short-term 
memory deficits was abolished by a muscarinic receptor antagonist, scopolamine. OBX 
down-regulated phosphorylation of synaptic plasticity-related signaling proteins: NR1 
subunit of N-methyl-D-aspartate receptor, glutamate receptor 1 (GluR1), and 
calmodulin-dependent kinase II but not cyclic AMP-responsive element binding protein 
(CREB), and reduced brain-derived neurotrophic factor (BDNF) mRNA in the 
hippocampus. OBX also reduced the expression level of choline acetyltransferase in the 
hippocampus and cholinergic neurons in the medial septum, and enlarged the size of 
lateral ventricle. BM administration reversed these OBX-induced neurochemical and 
histological alterations, except the decrease of GluR1 phosphorylation, and enhanced 
CREB phosphorylation. Moreover, BM treatment inhibited ex vivo activity of 
acetylcholinesterase in the brain. The effects of BM were quite similar to those of THA. 
Our findings demonstrate that BM treatment, as well as THA, ameliorates 
OBX-induced cognition dysfunction via a mechanism involving enhancement of synaptic 
plasticity-related signaling and BDNF transcription and protection of cholinergic 
systems from OBX-induced neuronal damage. 
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II. Endogenous acetylcholine rescues NMDA-induced long-lasting hippocampal cell 
damage via stimulation of muscarinic M1 receptors: Elucidation using organic 
hippocampal slice cultures (2) 
This study aimed to investigate a recuing role of cholinergic systems in the 
excitotoxicity-induced hippocampal cell damage using organotypic hippocampal slice 
cultures (OHSCs). OHSCs were prepared from 7-day-old mice and exposed to 3 μM 
N-methyl-D-aspartate (NMDA) for 24 hr. After washing out the NMDA, OHSCs were 
incubated in medium containing test drugs for 0–6 days. Hippocampal cell damage was 
evaluated by propidium iodide (PI) staining, immunofluorescence, and western blotting. 
NMDA (1–10 μM) dose-dependently damaged hippocampal cells. The toxic effect of 3μM 
NMDA was also observed at 3– 6 days, even after washing out NMDA, and was blocked 
by MK-801 from day 3 to day 6. Post-treatments with THA, donepezil, and galantamine 
reduced the NMDA-induced long-lasting hippocampal cell damage. The effect of THA 
was induced in a manner dependent on the incubation period after NMDA treatment 
and was confirmed by Nissl staining and immunostaining with NeuN, a marker of 
mature neurons. The effect of THA was attenuated by scopolamine and a muscarinic M1 
receptor antagonist, pirenzepine, but not by a muscarinic M3 receptor antagonist, 
darifenacin, or a nicotinic receptor antagonist, mecamylamine. The protein kinase C 
(PKC) inhibitor Ro-31-8220 abolished the effect of tacrine. The pretreatment with 
NMDA had no effect on the expression level of presynaptic cholinergic markers, choline 
acetyltransferase and vesicular acetylcholine transporter, in OHSCs. These results 
suggest that a low concentration of NMDA causes long-lasting hippocampal cell damage 
and that cholinergic systems play, via endogenous ACh stimulation of muscarinic M1 
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receptor, a rescuing role in the excitotoxicity-induced long-lasting hippocampal cell 
damage. 
 
III. Protective effects of Bacopa monnieri on ischemia-induced cognitive deficit: a 
possible contribution of bacopaside I and the underlying mechanism (3) 
In the previous study, we found that BM alcohol extract attenuated OBX-induced 
cognitive deficits and septum cholinergic neurons, suggesting beneficial effects of BM on 
dementia patients. This study was conducted to further clarify the anti-dementia effects 
of BM using T2VO-induced cognitive deficits in mice, an animal model of vascular 
dementia, and to investigate the constituent(s) that contribute to the action of BM using 
oxygen- and glucose-deprivation (OGD)-induced hippocampal cell damage as an in vitro 
model of ischemia. In in vivo experiments, T2VO mice were treated daily with BM (50 
and 100 mg/kg, p.o.) 1 week before and continuously 3 days after operation. In in vitro 
experiments, OHSCs were incubated with triterpenoid saponins from BM (bacosides) or 
MK-801 1 hr before and during a 45-min period of OGD. Neuronal cell damage in 
OHSCs was analyzed by PI uptake 24 hr after OGD. BM treatment significantly and 
dose-dependently ameliorated T2VO-induced impairment of spatial cognitive 
performance in the water maze test. In in vitro experiments using OHSCs, among the 
bacosides tested, bacopaside I (25 μM) was found to have a potent neuroprotective 
action against OGD-induced neuronal cell damage. Double staining with TUNEL and 
PI revealed that OGD caused necrosis and apoptosis and that bacopaside I attenuated 
the effects of OGD. The neuroprotective effect of bacopaside I was blocked by a PKC 
inhibitor Ro-31-8220 and a PI3K inhibitor LY294002 but not by an ERK inhibitor 
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U0126. OGD reduced the level of phospho-Akt (p-Akt), an anti-apoptotic factor, in 
OHSCs. This decrease was reversed by bacopaside I. Moreover, it was found that 
treatment with bacopaside I itself was able to increase the level of p-Akt in OHSCs. 
These findings suggest that BM is beneficial for prevention of cognitive deficits related 
to cerebral ischemia and that bacopaside I, via PKC and PI3K/Akt mechanisms, plays a 
role in the neuroprotective effect of BM. 
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